Literature DB >> 24855281

Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.

Sana Khan1, W Kline Bolton2.   

Abstract

Entities:  

Keywords:  cancer; cyclophosphamide; membranous nephropathy

Mesh：

Substances：

Year:  2014        PMID： 24855281      PMCID： PMC4046722          DOI： 10.2215/CJN.04130414

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  35 in total

1.  ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses.

Authors:  Anna-Lena Berg; Margret Arnadottir
Journal:  Nephrol Dial Transplant       Date:  2004-05       Impact factor: 5.992

2.  Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.

Authors:  A L Berg; P Nilsson-Ehle; M Arnadottir
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

3.  Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

Authors:  Alvaro Torres; Beatriz Domínguez-Gil; Agustín Carreño; Eduardo Hernández; Enrique Morales; Julian Segura; Ester González; Manuel Praga
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.

Authors:  Min Chen; Hang Li; Xia-Yu Li; Fu-Ming Lu; Zhao-Hui Ni; Fei-Fei Xu; Xue-Wang Li; Jiang-Hua Chen; Hai-Yan Wang
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

5.  Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.

Authors:  A J Branten; L J Reichert; R A Koene; J F Wetzels
Journal:  QJM       Date:  1998-05

6.  A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.

Authors:  Vivekanand Jha; Anirban Ganguli; Tarun K Saha; Harbir S Kohli; Kamal Sud; Krishan L Gupta; Kusum Joshi; Vinay Sakhuja
Journal:  J Am Soc Nephrol       Date:  2007-05-09       Impact factor: 10.121

Review 7.  Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

Authors:  A Knight; J Askling; F Granath; P Sparen; A Ekbom
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

8.  A controlled study of short-term prednisone treatment in adults with membranous nephropathy.

Authors: 
Journal:  N Engl J Med       Date:  1979-12-13       Impact factor: 91.245

9.  Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.

Authors:  Peggy W G du Buf-Vereijken; Amanda J W Branten; Jack F M Wetzels
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307
View more
  2 in total

Review 1.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

2.  Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy.

Authors:  Chengning Zhang; Suyan Duan; Miao Guo; Yanggang Yuan; Zhimin Huang; Jingfeng Zhu; Bin Sun; Bo Zhang; Changying Xing
Journal:  Pharmgenomics Pers Med       Date:  2020-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.